Science Corporation

Science Corporation is a clinical-stage, vertically integrated medical technology company developing advanced neural engineering platforms to restore quality of life for people with debilitating conditions. The company's lead product, PRIMA, is a retinal implant that uses a brain-computer interface to restore vision in patients with geographic atrophy due to age-related macular degeneration, retinitis pigmentosa, and Stargardt disease — with breakthrough results published in The New England Journal of Medicine. Beyond vision restoration, Science is building a full-stack neural engineering ecosystem spanning biohybrid neural interfaces, Axon Probes, vessel perfusion technology, and the Nexus software platform. The company also operates a Foundry division, offering its microfabrication capabilities to external research and commercial partners.